The Negative Cross-Talk between SAG/RBX2/ROC2 and APC/C E3 Ligases in Regulation of Cell Cycle Progression and Drug

Shizhen Zhang1, Yanwen Shen1, Hua Li2

  • 1Cancer Institute of the Second Affiliated Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou 310029, China.

Cell Reports
|September 9, 2020
PubMed

Insights

The E3 ligase SAG inhibits the anaphase-promoting complex/cyclosome (APC/C) to regulate cell cycle progression. This cross-talk ensures accurate cell division and response to anti-microtubule drugs.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • The anaphase-promoting complex/cyclosome (APC/C) is a crucial E3 ubiquitin ligase regulating cell cycle progression.
  • APC/C utilizes UBE2C and UBE2S E2 enzymes for K11-linked substrate ubiquitylation.
  • SAG (RBX2/ROC2), a component of Cullin-RING E3 ligases, also interacts with UBE2C/UBE2S for K11-linked polyubiquitylation.

Purpose of the Study:

  • To investigate the potential cross-talk between the APC/C and SAG E3 ligases.
  • To elucidate the role of SAG in regulating APC/C activity and cell cycle progression.
  • To understand the feedback mechanism involving APC/C-mediated degradation of SAG.

Main Methods:

  • Co-immunoprecipitation assays to study protein interactions.
  • Western blotting to assess protein levels and ubiquitylation.
  • Cell cycle analysis (e.g., flow cytometry) to monitor progression.
  • RNA interference (RNAi) for gene knockdown.
  • Site-directed mutagenesis to create degradation-resistant SAG variants.

Main Results:

  • SAG competes with APC2 for binding to UBE2C/UBE2S, acting as an endogenous inhibitor of APC/C.
  • SAG knockdown leads to premature APC/C activation, causing mitotic slippage and resistance to anti-microtubule agents.
  • SAG is a substrate of APC/CCDH1, targeted for degradation during the G1 phase.
  • A degradation-resistant SAG mutant (SAG-R98A/L101A) accelerates G1-to-S phase progression.

Conclusions:

  • A negative cross-talk exists between SAG and APC/C, where SAG inhibits APC/C activity and is subsequently degraded by APC/C.
  • This regulatory loop involving SAG and APC/C is critical for ensuring the fidelity of cell cycle progression.
  • The interplay between SAG and APC/C impacts cellular responses to anti-microtubule drugs and cell cycle checkpoint control.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
37.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K